News for Exelixis, Inc. (EX9.BE)

Published at

Feb 19, 2021 10:08 PM

by marketscreener.com

positive

positive

Exelixis : to Webcast Virtual Fireside Chat as Part of the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021

- Presentation to be webcast on www.exelixis.com - ... | February 19, 2021

EXEL EX9.MU EX9.F EX9.DE EX9.BE

Read more →
Published at

Feb 14, 2021 12:13 PM

by businessworld.in

positive

positive

Study reveals cabozantinib most effective treatment for metastatic papillary kidney cancer

ANI - Study reveals cabozantinib most effective treatment for metastatic papillary kidney cancer, , cabozantinib, effective treatment, papillary kidney cancer, John Wright, Latest health related study

ZEGA.SG ZEGA.MU ZEGA.F ZEGA.BE ZEG.SG ZEG.MU ZEG.F ZEG.DE ZEG.BE EXEL EX9.MU EX9.F EX9.DE EX9.BE AZNN.MX AZNCF

Read more →
Published at

Feb 12, 2021 11:16 PM

by marketscreener.com

mixed

mixed

Exelixis : Announces Final Phase 1 Results from Clinical Trial Sponsored by the National Cancer Institute at ASCO GU for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Patien

– Study demonstrated objective response rates of 38% in all patients, 62.5% in patients with renal cell carcinoma and 42.4% in patients with urothelial carcinoma – – Data to be... | February 12, 2021

EXEL EX9.MU EX9.F EX9.DE EX9.BE SEER

Read more →
Published at

Feb 11, 2021 7:03 AM

by seekingalpha.com

neutral

neutral

Exelixis' (EXEL) CEO Mike Morrissey on Q4 2020 Results - Earnings Call Transcript

Exelixis, Inc. (NASDAQ:EXEL) Q4 2020 Earnings Conference Call February 10, 2021, 5:00 PM ET Company Participants Susan Hubbard - Executive Vice President-Public Affairs and Investor...

EXEL EX9.MU EX9.F EX9.DE EX9.BE

Read more →
Published at

Feb 11, 2021 12:52 AM

by seekingalpha.com

neutral

neutral

Exelixis, Inc. 2020 Q4 - Results - Earnings Call Presentation (NASDAQ:EXEL)

The following slide deck was published by Exelixis, Inc.

EXEL EX9.MU EX9.F EX9.DE EX9.BE

Read more →
Published at

Feb 10, 2021 1:34 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 ...

XUPB.MU XUPB.F XUPB.BE XUP.MU XUP.F XUP.BE SQZ SAVA RGO.SG RGO.MU RGO.F RGO.BE REGN.MX REGN PX91.MU PX91.F PX91.BE PLX.TA PLX PBDA.MU PBDA.F PBDA.BE NARI LGND LGDN.F LGDN.BE KTRA KRTX KALV JAZZN.MX JAZZ J7Z.SG J7Z.MU J7Z.F J7Z.BE ITRM ITOS ITCI ILMN GNFTF GNFT.PA GNFT GMDA ENLV.TA ENLV DMPWW CDAK 4XC1.SG 4XC1.F 4XC1.BE 3DM.F 3DM.BE 32W.MU 32W.F 23I.MU 23I.F 23I.BE 1BT.F 1BT.BE VNDA VM4.SG VM4.F UG2.SG UG2.F UG2.BE TXMD TEVAN.MX TEVA TEV.F TERN SYBX SWTX SU6.F SU6.BE SRDX SLRX SESN SEEL RV7.MU RV7.F RV7.BE RGLS RDUS RCUS QIA.SG QIA.MU QIA.F QIA.DE QIA.BE QGEN PYPD PRTK PRTA PRLD PDSB PCBK.MU PCBK.F PCBK.BE PACB P09.SG P09.F P09.BE OTLK OPNT O7PA.MU O7PA.F NXEN.SG NXEN.F NXEN.BE NVV1.MU NVV1.F NVV1.BE NVCR NVAX.MX NVAX NOVN NMTR NK NBSE N4CN.SG N4CN.F N4CN.BE MREO MORF MINA.MU MINA.F MINA.BE MDXG MAH0.SG MAH0.MU MAH0.F MAH0.BE KMDA.TA KMDA INSP ILU.SG ILU.MU ILU.F ILU.DE ILU.BE ILMN.MX IDYA HAZ.MU HAZ.F HALO HAE GKOS GHSI FP11.F FLGT.MX FLGT FLDM FLB.MU FLB.F FLB.BE EYEN EXEL EX9.MU EX9.F EX9.DE EX9.BE EVGN.TA EVGN EU6.F ETON EJU.MU EJU.F EJU.BE EDAP EDA.F EDA.BE DRIO CXF.MU CXF.F CXF.BE COLL CMRX CLPT CELC CCXI CBMG BBIO ASLN ARGX.BR ARGX APVO AP8N.MU AP8N.F ANGO AMRX AGIO AEMD ABCL 8QQ.HM 8AP.MU 8AP.F 7RG1.F 7F0.F 7F0.BE 7A9.MU 7A9.F 7A9.BE 6LU.F 6LU.BE 6GJ.F 41ON.SG 41ON.MU 41ON.F 41ON.BE 354.F 31Y.MU 31Y.F 30J.MU 30J.F 30J.BE 2Q3.F 2Q3.BE 2DR.MU 2DR.F 2DR.BE 2CX.SG 2CX.MU 2CX.BE 2CL.MU 2CL.F 29T.F 29T.BE 1R8.SG 1R8.F 1R8.BE 1AEA.MU 1AE.SG 1AE.MU 1AE.F 1AE.BE 0PT.F 038.MU 038.F 038.DU ZSAN XNCR XE9.SG XE9.MU XE9.F XE9.BE VRCA VERU VCYT VCEL LLY.SG LLY.F LLY.DE LLY.BA LLY FMW.MU FMW.F FMW.BE ATQP.SG ATQP.MU ATQP.F ATQP.BE 1NE.MU 1NE.F 12V.F 12V.BE 0ZPN.SG 0ZPN.F 0ZPN.BE

Read more →
Published at

Feb 9, 2021 9:47 PM

by seekingalpha.com

mixed

mixed

Bristol Myers announce new late-stage data for Opdivo/ Cabometyx combo in kidney cancer (NYSE:BMY)

Bristol Myers Squibb (NYSE: BMY) and Exelixis, Inc. (NASDAQ:EXEL) disclosed new data for Opdivo/ Cabometyx combo in a pivotal Phase 3 trial for the first-line treatment of advanced renal...

EXEL EX9.MU EX9.F EX9.DE EX9.BE BMY

Read more →
Published at

Feb 9, 2021 1:13 PM

by benzinga.com

neutral

neutral

Opdivo Plus Cabometyx Combo Shows Superior Clinical Benefit Versus Sunitinib In Late-Stage Kidney Cancer Study

Bristol Myers Squibb Co (NYSE: BMY) and Exelixis Inc (NASDAQ: EXEL) have announced updated data from Phase 3 ...

EXEL EX9.MU EX9.F EX9.DE EX9.BE BRM.SG BRM.MU BRM.F BRM.DE BRM.BE BMYMP BMY.MX BMY

Read more →
Published at

Feb 6, 2021 6:42 PM

by markets.businessinsider.com

mixed

mixed

The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A acti...

TKPHF TKDA.SG TKDA.MU TKDA.F TKDA.BE TKD.SG TKD.MU TKD.F TKD.BE TAK NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX MRK.PA MRK.MX LGVN JAZZN.MX JAZZ J7Z.SG J7Z.MU J7Z.F J7Z.BE GWPRF GWPH CLVS C6O.MU C6O.F C6O.DE C6O.BE BX2.MU BX2.F BX2.BE BTAI BMY 6MK.MU 6MK.F 6MK.DE 6MK.BE 4502.T VNDA VM4.SG VM4.F VERU UP0.SG UP0.F SU6.F SU6.BE SRDX RGNX REGN RB0.MU RB0.F RB0.BE RARE PYPD PLX.TA PLX PCJP.F PCJP.BE PBDA.MU PBDA.F PBDA.BE PACB P09.SG P09.F P09.BE OTIC OT1A.MU OT1A.F OT1A.BE ORTX MYOV KPTI KOD.MX KOD K27.MU K27.F K27.BE INFI INCY IMU.MU IMU.F IMU.DE IMU.BE ILU.SG ILU.MU ILU.F ILU.DE ILU.BE ILMN.MX ILMN ICY.MU ICY.F ICY.BE I3F.MU I3F.F I3F.BE GMDA GENE FMW.MU FMW.F FMW.BE FLDM FLB.MU FLB.F FLB.BE EXEL EX9.MU EX9.F EX9.DE EX9.BE EQ ENTA EJU.MU EJU.F EJU.BE DUL.MU DUL.F DUL.DE DNLI DCPH D05.MU D05.F AYTUZ AYTUW AYTU AVRO ALNY ALKS AGTC AEMD ABEO 9EP.MU 9EP.F 7OT.MU 7OT.F 71M.SG 71M.F 71M.BE 4DN.SG 4DN.MU 4DN.F 4DN.BE 2GT.MU 2GT.F 2GT.BE 25K.SG 25K.MU 25K.F 25K.BE 0FY.MU 0FY.F 0FY.BE MRK IMGN ADAG

Read more →
Published at

Feb 6, 2021 6:39 PM

by benzinga.com

mixed

mixed

The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO ...

TKPHF TKDA.SG TKDA.MU TKDA.F TKDA.BE TKD.SG TKD.MU TKD.F TKD.BE TAK NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX MRK.PA MRK.MX LGVN JAZZN.MX JAZZ J7Z.SG J7Z.MU J7Z.F J7Z.BE GWPRF GWPH CLVS C6O.MU C6O.F C6O.DE C6O.BE BX2.MU BX2.F BX2.BE BTAI BMY 6MK.MU 6MK.F 6MK.DE 6MK.BE 4502.T VNDA VM4.SG VM4.F VERU UP0.SG UP0.F SU6.F SU6.BE SRDX RGNX REGN RB0.MU RB0.F RB0.BE RARE PYPD PLX.TA PLX PCJP.F PCJP.BE PBDA.MU PBDA.F PBDA.BE PACB P09.SG P09.F P09.BE OTIC OT1A.MU OT1A.F OT1A.BE ORTX MYOV KPTI KOD.MX KOD K27.MU K27.F K27.BE INFI INCY IMU.MU IMU.F IMU.DE IMU.BE ILU.SG ILU.MU ILU.F ILU.DE ILU.BE ILMN.MX ILMN ICY.MU ICY.F ICY.BE I3F.MU I3F.F I3F.BE GMDA GENE FMW.MU FMW.F FMW.BE FLDM FLB.MU FLB.F FLB.BE EXEL EX9.MU EX9.F EX9.DE EX9.BE EQ ENTA EJU.MU EJU.F EJU.BE DUL.MU DUL.F DUL.DE DNLI DCPH D05.MU D05.F AYTUZ AYTUW AYTU AVRO ALNY ALKS AGTC AEMD ABEO 9EP.MU 9EP.F 7OT.MU 7OT.F 71M.SG 71M.F 71M.BE 4DN.SG 4DN.MU 4DN.F 4DN.BE 2GT.MU 2GT.F 2GT.BE 25K.SG 25K.MU 25K.F 25K.BE 0FY.MU 0FY.F 0FY.BE MRK IMGN ADAG

Read more →
Published at

Feb 3, 2021 7:47 PM

by investopedia.com

mixed

mixed

Best Biotech ETFs for Q2 2021

The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.

VIR TDOC.MX TDOC RGO.SG RGO.MU RGO.F RGO.BE REGN.MX REGN NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX LGND LGDN.F LGDN.BE 4LL.SG 4LL.MU 4LL.F 4LL.BE TWST PACB P09.SG P09.F P09.BE FATE F6T.F F6T.BE 0ME.MU 0ME.F 0ME.BE EXEL EX9.MU EX9.F EX9.DE EX9.BE BGNE 6160.HK 49BA.SG

Read more →
Published at

Jan 21, 2021 5:33 PM

by etftrends.com

mixed

mixed

4Q 2020 – Small Cap Trails Record Russell 2000 Gain

Anticipating strong economic and earnings gains in 2021 after the COVID-inspired recession in 2020, broad stock indices continued their hefty rally in 2020’s fourth quarter.

VRTS VIP.F QGJ.F EVR UFPI UF3.F UF3.BE EXEL EX9.MU EX9.F EX9.DE EX9.BE ER4.F ER4.BE EBS AVX.F AVX.BE AEIS

Read more →